(Q46979399)

27 December 2017

title

Time-course-dependent microvascular alterations in a model of myeloid leukemia in vivo (English)

1 reference

27 December 2017

1 reference

C Schaefer

1

1 reference

27 December 2017

M Krause

2

1 reference

27 December 2017

I Fuhrhop

3

1 reference

27 December 2017

M Schroeder

4

1 reference

27 December 2017

P Algenstaedt

5

1 reference

27 December 2017

W Fiedler

6

1 reference

27 December 2017

W Rüther

7

1 reference

27 December 2017

N Hansen-Algenstaedt

8

1 reference

27 December 2017

publication date

27 September 2007

1 reference

27 December 2017

published in

Leukemia

1 reference

27 December 2017

volume

22

1 reference

27 December 2017

issue

1

1 reference

27 December 2017

page(s)

59-65

1 reference

27 December 2017

https://scigraph.springernature.com/pub.10.1038/sj.leu.2404947

exact match

0 references

cites work

Role of angiogenesis in tumor growth and metastasis

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2404947

Microvessel density predicts survival in prostate cancer patients subjected to watchful waiting

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2404947

Paradoxical roles of the immune system during cancer development

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2404947

7 January 2021

Mechanisms of angiogenesis and arteriogenesis

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2404947

7 January 2021

In vivo imaging of specialized bone marrow endothelial microdomains for tumour engraftment

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2404947

7 January 2021

Drug penetration in solid tumours

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2404947

7 January 2021

Role of the microenvironment in promoting angiogenesis in acute myeloid leukemia

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2404947

7 January 2021

VEGF and myeloid leukemias

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2404947

7 January 2021

The Eugene M. Landis Award Lecture 1996. Delivery of molecular and cellular medicine to solid tumors

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2404947

7 January 2021

Tipifarnib and bortezomib are synergistic and overcome cell adhesion-mediated drug resistance in multiple myeloma and acute myeloid leukemia

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2404947

7 January 2021

Bone marrow stromal-derived soluble factors and direct cell contact contribute to de novo drug resistance of myeloma cells by distinct mechanisms

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2404947

7 January 2021

Selective growth response to IL-3 of a human leukaemic cell line with megakaryoblastic features.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2404947

7 January 2021

Long-term observation reveals time-course-dependent characteristics of tumour vascularisation

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2404947

7 January 2021

Application of the “two-slit” photometric technique to the measurement of microvascular volumetric flow rates

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2404947

7 January 2021

A comparison of tumor and normal tissue microvascular hematocrits and red cell fluxes in a rat window chamber model

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2404947

7 January 2021

Overexpression of vascular endothelial growth factor (VEGF) and its cellular receptor KDR (VEGFR-2) in the bone marrow of patients with acute myeloid leukemia

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2404947

7 January 2021

Inhibitors of angiogenesis selectively reduce the malignant cell load in rodent models of human myeloid leukemias

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2404947

7 January 2021

Quantitation and gompertzian analysis of tumor growth

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2404947

7 January 2021

High interstitial fluid pressure - an obstacle in cancer therapy

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2404947

7 January 2021

Angiogenesis in cancer and other diseases

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2404947

7 January 2021

Site-dependent angiogenic cytokine production in human tumor xenografts

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2404947

7 January 2021

Tumor angiogenesis: a new significant and independent prognostic indicator in early-stage breast carcinoma

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2404947

7 January 2021

The next frontier of molecular medicine: delivery of therapeutics.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2404947

7 January 2021

Interstitial pH and pO2 gradients in solid tumors in vivo: high-resolution measurements reveal a lack of correlation

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2404947

7 January 2021

Quantification of longitudinal tissue pO2 gradients in window chamber tumours: impact on tumour hypoxia

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2404947

7 January 2021

Pathology: cancer cells compress intratumour vessels.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2404947

7 January 2021

Geometric resistance and microvascular network architecture of human colorectal carcinoma

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2404947

7 January 2021

The distribution of the anticancer drug Doxorubicin in relation to blood vessels in solid tumors.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2404947

7 January 2021

Leukocyte-endothelial adhesion and angiogenesis in tumors

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2404947

7 January 2021

Increased microvascular density and enhanced leukocyte rolling and adhesion in the skin of VEGF transgenic mice

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2404947

7 January 2021

Tumor angiogenesis factors reduce leukocyte adhesion in vivo.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2404947

7 January 2021

Leukocytes roll on a selectin at physiologic flow rates: distinction from and prerequisite for adhesion through integrins.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2404947

7 January 2021

Anti-angiogenesis therapy can overcome endothelial cell anergy and promote leukocyte-endothelium interactions and infiltration in tumors.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2404947

7 January 2021

The protein tyrosine kinase inhibitor SU5614 inhibits VEGF-induced endothelial cell sprouting and induces growth arrest and apoptosis by inhibition of c-kit in AML cells

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2404947

7 January 2021

Downregulation of VEGF-A, STAT5 and AKT in acute myeloid leukemia blasts of patients treated with SU5416.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2404947

7 January 2021

Identifiers

DOI

10.1038/SJ.LEU.2404947

1 reference

27 December 2017

1 reference

27 December 2017